BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35323375)

  • 1. Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.
    Buja A; Rugge M; De Luca G; Bovo E; Zorzi M; De Toni C; Cozzolino C; Vecchiato A; Del Fiore P; Spina R; Cinquetti S; Baldo V; Rossi CR; Mocellin S
    Curr Oncol; 2022 Mar; 29(3):2165-2173. PubMed ID: 35323375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of having a home garden on personal UVR exposure behavior and risk of cutaneous malignant melanoma in Denmark.
    Idorn LW; Thieden E; Philipsen PA; Wulf HC
    Int J Cancer; 2013 Mar; 132(6):1383-8. PubMed ID: 22821769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet radiation and malignant melanoma.
    Moan J; Porojnicu AC; Dahlback A
    Adv Exp Med Biol; 2008; 624():104-16. PubMed ID: 18348451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population exposure to ultraviolet radiation in Finland 1920-1995: Exposure trends and a time-series analysis of exposure and cutaneous melanoma incidence.
    Kojo K; Jansen CT; Nybom P; Huurto L; Laihia J; Ilus T; Auvinen A
    Environ Res; 2006 May; 101(1):123-31. PubMed ID: 16290819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.
    Ghazawi FM; Le M; Lagacé F; Cyr J; Alghazawi N; Zubarev A; Roy SF; Rahme E; Netchiporouk E; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
    J Cutan Med Surg; 2019; 23(4):394-412. PubMed ID: 31132871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous melanoma in older patients.
    Buja A; Rugge M; Trevisiol C; Zanovello A; Brazzale AR; Zorzi M; Vecchiato A; Del Fiore P; Tropea S; Rastrelli M; Rossi CR; Mocellin S
    BMC Geriatr; 2024 Mar; 24(1):232. PubMed ID: 38448833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cutaneous malignant melanoma in Israel, 1960-1989.
    Iscovich J; Andreev H; Steinitz R
    Public Health Rev; 1995; 23(1):1-23. PubMed ID: 7761605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018.
    Memon A; Bannister P; Rogers I; Sundin J; Al-Ayadhy B; James PW; McNally RJQ
    Lancet Reg Health Eur; 2021 Mar; 2():100024. PubMed ID: 34557790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of cutaneous malignant melanoma in Reunion Island.
    Chirpaz E; Warocquier J; Filisetti C; Beylot-Barry M; Bertolotti A; Sultan N
    Ann Dermatol Venereol; 2022 Mar; 149(1):39-44. PubMed ID: 35131081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic status and cutaneous malignant melanoma in Northern Europe.
    Idorn LW; Wulf HC
    Br J Dermatol; 2014 Apr; 170(4):787-93. PubMed ID: 24359255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological aspects of cutaneous malignant melanoma (review).
    Serraino D; Fratino L; Gianni W; Campisi C; Pietropaolo M; Trimarco G; Marigliano V
    Oncol Rep; 1998; 5(4):905-9. PubMed ID: 9625843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Season of birth and other perinatal risk factors for melanoma.
    Crump C; Sundquist K; Sieh W; Winkleby MA; Sundquist J
    Int J Epidemiol; 2014 Jun; 43(3):793-801. PubMed ID: 24453238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet radiation and cutaneous malignant melanoma.
    Moan JE; Baturaite Z; Dahlback A; Porojnicu AC
    Adv Exp Med Biol; 2014; 810():359-74. PubMed ID: 25207376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade.
    Li S; Tang T; Han J; Liu W; Chen R; Deng H; Jian T; Fu Z
    Cancer Epidemiol; 2024 Feb; 88():102515. PubMed ID: 38176331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma in Denmark. Occurrence and risk factors.
    Osterlind A
    Acta Oncol; 1990; 29(7):833-54. PubMed ID: 2261197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sun behaviour after cutaneous malignant melanoma: a study based on ultraviolet radiation measurements and sun diary data.
    Idorn LW; Datta P; Heydenreich J; Philipsen PA; Wulf HC
    Br J Dermatol; 2013 Feb; 168(2):367-73. PubMed ID: 23013402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
    Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
    Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
    Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
    J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy.
    Bucchi L; Mancini S; Crocetti E; Dal Maso L; Baldacchini F; Vattiato R; Giuliani O; Ravaioli A; Caldarella A; Carrozzi G; Ferretti S; Filiberti RA; Fusco M; Gatti L; Gili A; Magoni M; Mangone L; Mazzoleni G; Michiara M; Panato C; Piffer S; Piras D; Rosso S; Rugge M; Scala U; Tagliabue G; Tumino R; Stanganelli I; Falcini F
    Int J Cancer; 2021 Feb; 148(4):835-844. PubMed ID: 33405292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.